Matches in Wikidata for { <http://www.wikidata.org/entity/Q93085767> ?p ?o ?g. }
- Q93085767 description "2019 nî lūn-bûn" @default.
- Q93085767 description "2019年の論文" @default.
- Q93085767 description "2019年学术文章" @default.
- Q93085767 description "2019年学术文章" @default.
- Q93085767 description "2019年学术文章" @default.
- Q93085767 description "2019年学术文章" @default.
- Q93085767 description "2019年学术文章" @default.
- Q93085767 description "2019年学术文章" @default.
- Q93085767 description "2019年學術文章" @default.
- Q93085767 description "2019年學術文章" @default.
- Q93085767 description "2019年學術文章" @default.
- Q93085767 description "2019年學術文章" @default.
- Q93085767 description "2019年學術文章" @default.
- Q93085767 description "2019년 논문" @default.
- Q93085767 description "article científic" @default.
- Q93085767 description "article scientific" @default.
- Q93085767 description "article scientifique" @default.
- Q93085767 description "articol științific" @default.
- Q93085767 description "articolo scientifico" @default.
- Q93085767 description "artigo científico" @default.
- Q93085767 description "artigo científico" @default.
- Q93085767 description "artigo científico" @default.
- Q93085767 description "artikel ilmiah" @default.
- Q93085767 description "artikull shkencor" @default.
- Q93085767 description "artikulong pang-agham" @default.
- Q93085767 description "artykuł naukowy" @default.
- Q93085767 description "artículo científico publicado en 2019" @default.
- Q93085767 description "artículu científicu" @default.
- Q93085767 description "bilimsel makale" @default.
- Q93085767 description "bài báo khoa học" @default.
- Q93085767 description "naučni članak" @default.
- Q93085767 description "scienca artikolo" @default.
- Q93085767 description "scientific article published on 03 September 2019" @default.
- Q93085767 description "scientific article published on 3 September 2019" @default.
- Q93085767 description "scientific article published on 3 September 2019" @default.
- Q93085767 description "teaduslik artikkel" @default.
- Q93085767 description "tieteellinen artikkeli" @default.
- Q93085767 description "tudományos cikk" @default.
- Q93085767 description "vedecký článok" @default.
- Q93085767 description "vetenskaplig artikel" @default.
- Q93085767 description "videnskabelig artikel udgivet 3. september 2019" @default.
- Q93085767 description "vitenskapelig artikkel" @default.
- Q93085767 description "vitskapeleg artikkel" @default.
- Q93085767 description "vědecký článek" @default.
- Q93085767 description "wetenschappelijk artikel" @default.
- Q93085767 description "wissenschaftlicher Artikel" @default.
- Q93085767 description "επιστημονικό άρθρο" @default.
- Q93085767 description "мақолаи илмӣ" @default.
- Q93085767 description "наукова стаття, опублікована у вересні 2019" @default.
- Q93085767 description "научна статия" @default.
- Q93085767 description "научная статья" @default.
- Q93085767 description "научни чланак" @default.
- Q93085767 description "научни чланак" @default.
- Q93085767 description "מאמר מדעי" @default.
- Q93085767 description "مقالة علمية نشرت في 3 سبتمبر 2019" @default.
- Q93085767 description "৩ সেপ্টেম্বর ২০১৯-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q93085767 description "บทความทางวิทยาศาสตร์" @default.
- Q93085767 description "სამეცნიერო სტატია" @default.
- Q93085767 name "Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes" @default.
- Q93085767 name "Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes" @default.
- Q93085767 type Item @default.
- Q93085767 label "Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes" @default.
- Q93085767 label "Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes" @default.
- Q93085767 prefLabel "Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes" @default.
- Q93085767 prefLabel "Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes" @default.
- Q93085767 P1104 Q93085767-E8204124-D24D-4E25-BE59-2EB958727944 @default.
- Q93085767 P1433 Q93085767-CE8CB736-37D9-4FFE-A370-66F1AE63F920 @default.
- Q93085767 P1476 Q93085767-9D79D769-F357-42B5-B4A0-F0FF1557215A @default.
- Q93085767 P2093 Q93085767-0013D3C2-6D8D-40B7-B775-7194A775CA45 @default.
- Q93085767 P2093 Q93085767-100BEC7B-FD80-44D9-B9B8-79C008D89217 @default.
- Q93085767 P2093 Q93085767-12B94A31-B9E7-4E6E-BA8F-76511187BD85 @default.
- Q93085767 P2093 Q93085767-161AB198-4DD9-45CC-8B6C-F1955BD30749 @default.
- Q93085767 P2093 Q93085767-1BFF6B64-3FFD-4680-A28C-AFA19461C813 @default.
- Q93085767 P2093 Q93085767-30AEFE53-4680-4712-A726-B7D98942DB7F @default.
- Q93085767 P2093 Q93085767-31DCC1A7-7011-4134-93FE-A53CE178B60E @default.
- Q93085767 P2093 Q93085767-3B5A4E56-2D9F-4AF7-AA7E-43BC47EE85E7 @default.
- Q93085767 P2093 Q93085767-3B99D6E9-7F69-45D4-902D-D06EC3525856 @default.
- Q93085767 P2093 Q93085767-3D584D9D-D023-4DC2-B8BF-8C8708A35FBB @default.
- Q93085767 P2093 Q93085767-415A9D22-EA8D-421A-B1E0-715DD4E16372 @default.
- Q93085767 P2093 Q93085767-44E78B08-BAA4-48AB-9638-F4A2C2895DA4 @default.
- Q93085767 P2093 Q93085767-6194461C-AAEB-4790-9AEE-F911AE5A656D @default.
- Q93085767 P2093 Q93085767-7669A157-4EC7-4844-80DB-82488D16858B @default.
- Q93085767 P2093 Q93085767-87860A9A-0F6B-408A-A06C-F66B9690F9A4 @default.
- Q93085767 P2093 Q93085767-BF08434C-667E-4DDE-AB81-3F71980C9D06 @default.
- Q93085767 P2093 Q93085767-F628BCAB-385D-411C-BD82-CCA16EEFAE4A @default.
- Q93085767 P304 Q93085767-197F90C2-051E-43AD-BFFD-BD843EDF4E42 @default.
- Q93085767 P31 Q93085767-BC3A4EEE-58A6-4DFA-ACEB-E0D3FC0DEC4E @default.
- Q93085767 P356 Q93085767-664D11FE-F3AF-4C36-87BC-384F9EEBB23A @default.
- Q93085767 P433 Q93085767-DA976801-BDF9-46F8-891D-ADCA57F99690 @default.
- Q93085767 P478 Q93085767-736B01B1-ECF4-43E4-A600-CF3E48B6D2EB @default.
- Q93085767 P50 Q93085767-80B8C0EA-5FEE-4A51-833C-7D92A4B6D8A8 @default.
- Q93085767 P50 Q93085767-A43C7DC0-1D0E-46B3-9F18-7FADDCD71A60 @default.
- Q93085767 P50 Q93085767-C964581E-9799-4A85-926B-50EE7AFE214E @default.
- Q93085767 P577 Q93085767-F363051D-EF0C-4117-A18D-27DD83ED0FC5 @default.
- Q93085767 P698 Q93085767-B35FAE9F-6A09-4BB0-9D57-2BB96B2A4631 @default.
- Q93085767 P356 1078-0432.CCR-19-1338 @default.
- Q93085767 P698 31481511 @default.
- Q93085767 P1104 "+10" @default.
- Q93085767 P1433 Q332253 @default.
- Q93085767 P1476 "Phase II Study of the ALK5 Inhibitor Galunisertib in Very Low-, Low-, and Intermediate-Risk Myelodysplastic Syndromes" @default.